Brefonalol
Alternative Names: BDF 8186; BrefanololLatest Information Update: 24 Mar 1997
At a glance
- Originator Beiersdorf
- Class Antihypertensives; Ischaemic heart disorder therapies
- Mechanism of Action Alpha adrenergic receptor antagonists; Beta adrenergic receptor antagonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Angina pectoris; Arrhythmias; Hypertension
Most Recent Events
- 24 Mar 1997 Discontinued-II for Hypertension in Germany (Unknown route)